Showing results (1-10 of 4) with videos related to
Sort By:
Pageof 1
Hemasphere|May 6, 2021
Pharmacological Inhibition of Insulin Growth Factor-1 Receptor (IGF-1R) Alone or in Combination With Ruxolitinib Shows Therapeutic Efficacy in Preclinical Myeloproliferative Neoplasm ModelsTitiksha Basu, Hannah Bertrand, Nikolaos Karantzelis, et al.International Journal of Molecular Sciences|December 30, 2025
NFE2 Truncation Mutants Protect Wild-Type NFE2 from ITCH-Dependent DegradationMirjam Elisabeth Hoeness, Franziska Zell, Titiksha Basu, et al.Blood|February 14, 2019
Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrationsJonas Samuel Jutzi, Titiksha Basu, Maximilian Pellmann, et al.Leukemia & Lymphoma|January 8, 2015
Phase I dose escalation study of lestaurtinib in patients with myelofibrosisElizabeth O Hexner, John Mascarenhas, Josef Prchal, et al.Pageof 1